SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

Фармакология - колоквиум 2

» Start this Course
(Practice similar questions for free)
Question:

Adalimumab

Author: Viyana Angelova



Answer:

TNF-L блокиращи биологични болест-модифициращи антиревматоидни лекарства


0 / 5  (0 ratings)

1 answer(s) in total